1986
DOI: 10.1007/bf00635896
|View full text |Cite
|
Sign up to set email alerts
|

The pharmacokinetics of timegadine and two of its metabolites after multiple oral dosing, and the effects of concomitant administration of ibuprofen

Abstract: A 250 mg tablet of timegadine was given twice daily for 15 days to 13 healthy volunteers. On Day 16 a single morning dose of timegadine was supplemented by two 200 mg tablets of a proprietary brand of ibuprofen. Serum concentrations of timegadine were measured by high pressure liquid chromatography, and steady state was achieved between Days 5 and 8. Serum concentrations of two metabolites of timegadine, MI and MII were measured by thin layer chromatography by Leo Pharmaceutical Products, Denmark. Ibuprofen di… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

1988
1988
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 17 publications
0
3
0
Order By: Relevance
“…This time interval was chosen considering that 14 days would cover a minimum of four to six half‐lives of the medications on the Beers Criteria (allowing drugs to reach steady states with constant dosing). The interval allowed an adequate evaluation of the association between PIM prescribing and clinical outcomes 21–27 . Patients were followed up after an initial prescription fill until the date of hospitalizations or ED visits or upon the study's conclusion (30 September 2016).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…This time interval was chosen considering that 14 days would cover a minimum of four to six half‐lives of the medications on the Beers Criteria (allowing drugs to reach steady states with constant dosing). The interval allowed an adequate evaluation of the association between PIM prescribing and clinical outcomes 21–27 . Patients were followed up after an initial prescription fill until the date of hospitalizations or ED visits or upon the study's conclusion (30 September 2016).…”
Section: Methodsmentioning
confidence: 99%
“…The interval allowed an adequate evaluation of the association between PIM prescribing and clinical outcomes. [21][22][23][24][25][26][27] Patients were followed up after an initial prescription fill until the date of hospitalizations or ED visits or upon the study's conclusion (30 September 2016).…”
Section: Evaluation Of Clinical Outcomes Of Hospitalizations and Ed V...mentioning
confidence: 99%
“…( 2.4-9.7) (3.7-9.9) (3.6-9.4) (4.3-9.7) (3.8-9.4) volunteers, 250 mg b.i.d., results in maximal serum concentrations of 1.71 k0.16 pg/ml, equal to (4.26k0.40) x M, under steady state conditions (George et al 1986). As seen in fig.…”
Section: Lo-'mentioning
confidence: 96%